Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 1/20 | 0.46 |
| ▸ | JAK3 | P52333 | 1/20 | 0.46 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PMM2 | O15305 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.36 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15630072 | 0.85 | JAK2 (0.41) | JAK2JAK3NR3C1CYP1A2METAP2 | |
| SCHEMBL30107773 | 0.84 | MAPT (0.42) | JAK2JAK3NR3C1CYP1A2METAP2 | |
| SCHEMBL13174245 | 0.84 | ATM (0.41) | JAK2NR3C1KDM4EATML3MBTL1 | |
| SCHEMBL17281762 | 0.82 | ATM (0.42) | JAK2NR3C1KDM4EATML3MBTL1 | |
| SCHEMBL17281732 | 0.82 | ATM (0.42) | JAK2NR3C1KDM4EATML3MBTL1 | |
| SCHEMBL20633120 | 0.82 | ATM (0.42) | JAK2NR3C1KDM4EATML3MBTL1 | |
| SCHEMBL14407570 | 0.82 | KDM4E (0.52) | JAK2JAK3CYP1A2METAP2KDM4E | |
| SCHEMBL17281724 | 0.82 | ATM (0.42) | JAK2NR3C1KDM4EATML3MBTL1 | |
| SCHEMBL17281751 | 0.82 | ATM (0.42) | JAK2NR3C1KDM4EATML3MBTL1 | |
| SCHEMBL17281631 | 0.82 | ATM (0.42) | JAK2NR3C1KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200335706-A1 | Organic Electroluminescence Device | UDC IRELAND LTD (IE) | 2020-10-22 | — | — | US | disclosed |
| US-20190169097-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | UDC IRELAND LTD (IE) | 2019-06-06 | — | — | US | disclosed |
| US-20180130957-A1 | Organic Electroluminescence Device | UDC IRELAND LTD (IE) | 2018-05-10 | — | — | US | disclosed |
| US-20180130957-A1 | Organic Electroluminescence Device | UDC IRELAND LTD (IE) | 2018-05-10 | — | — | US | disclosed |
| US-9676717-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2017-06-13 | — | — | US | disclosed |
| US-9676717-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2017-06-13 | — | — | US | disclosed |
| US-9133118-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2015-09-15 | — | — | US | disclosed |
| US-9133118-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2015-09-15 | — | — | US | disclosed |
| US-8735878-B2 | Charge transporting material and organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2014-05-27 | — | — | US | disclosed |
| US-8735878-B2 | Charge transporting material and organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2014-05-27 | — | — | US | disclosed |
| US-20120313510-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-12-13 | — | — | US | disclosed |
| US-20120313510-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-12-13 | — | — | US | disclosed |
| US-20120298977-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120298977-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120292607-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120292607-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-11-22 | — | — | US | disclosed |
| US-20120280218-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-11-08 | — | — | US | disclosed |
| US-20120280218-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-11-08 | — | — | US | disclosed |
| US-20120256173-A1 | CHARGE TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-10-11 | — | — | US | disclosed |
| US-20120256173-A1 | CHARGE TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169097-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | EPCAM, ORC3, L1CAM | JAK2 3059/4885JAK3 1495/4885NR3C1 1124/4885 |
| US-20180130957-A1 | Organic Electroluminescence Device | RIF1, NCS1, MCM5 | JAK2 4760/4885JAK3 4722/4885NR3C1 2677/4885 |
| US-20120256173-A1 | CHARGE TRANSPORTING MATERIAL AND ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, SLC39A3, SLC39A11 | JAK2 3757/4885JAK3 4033/4885NR3C1 1603/4885 |
| US-20200335706-A1 | Organic Electroluminescence Device | RIF1, NCS1, MCM5 | JAK2 4760/4885JAK3 4722/4885NR3C1 2677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.